Verition Fund Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,000
Closed -$248K 3052
2022
Q3
$248K Hold
25,000
﹤0.01% 2362
2022
Q2
$245K Hold
25,000
﹤0.01% 1831
2022
Q1
$245K Hold
25,000
﹤0.01% 2259
2021
Q4
$243K Hold
25,000
﹤0.01% 2125
2021
Q3
$244K Hold
25,000
﹤0.01% 1539
2021
Q2
$241K Buy
+25,000
New +$244K ﹤0.01% 1468

Other funds holding MSAC

Verition Fund Management's MSAC Position: Q4 2022 in Review

Verition Fund Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q4 2022, closing a stake of 25,000 shares — an estimated $248K sold.

Verition Fund Management first reported a position in MSAC in Q2 2021 and held it in 6 quarters. The position peaked at $248K in Q3 2022. 49 funds tracked by Wall St. Rank hold MSAC as of Q4 2022.

  • Verition Fund Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 25,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q4 2022, an estimated $248K.
  • Verition Fund Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 6 quarters.
  • Verition Fund Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $248K in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.